Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

*Product:*	Zejula
Active Ingredient:	Niraparib tosilate monohydrate 159.4mg equivalent to niraparib 100mg
Dosage Form:	Capsule
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturer:	Quotient Sciences – Philadelphia LLC, Pennsylvania, United States of America

Dated this 14th day of March 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule